|
| Status |
Public on Mar 19, 2024 |
| Title |
IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota. |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
38781213 |
| |
| Submission date |
Jul 03, 2023 |
| Last update date |
Jun 18, 2024 |
| Contact name |
Bastian Opitz |
| Organization name |
Charité – Universitätsmedizin Berlin
|
| Department |
Department of Infectious Diseases, Respiratory Medicine and Critical Care
|
| Street address |
Augustenburgerplatz 1
|
| City |
Berlin |
| ZIP/Postal code |
13353 |
| Country |
Germany |
| |
|
| Platforms (1) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (80)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE236341 |
IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota [bulk RNA-seq] |
| GSE236342 |
IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota [scRNA-seq] |
| GSE236343 |
IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota [shotgun sequencing] |
|
| Relations |
| BioProject |
PRJNA990658 |
Less...
More...